Thymoquinone-Loaded Nanostructured Lipid Carrier Exhibited Cytotoxicity towards Breast Cancer Cell Lines (MDA-MB-231 and MCF-7) and Cervical Cancer Cell Lines (HeLa and SiHa)

Table 2

Drug encapsulation efficiency of TQ-NLC at 0 weeks and 24 weeks after synthesis.

Formulation	Duration of storage (week)	Drug encapsulation efficiency (%)	Drug loading capacity; (mg per mg of lipid)
TQ-NLC	0	97.63 ± 0.1798	97.63 ± 0.1798
	24	95.94 ± 0.2562^*	95.94 ± 0.2562^*

Values were the means of three replicate samples. The data were presented as mean ± SEM. * were significant as compared to 0 weeks of storage duration.